Pasithea Therapeutics Corp.
KTTA·NasdaqCM·Healthcare
0.53000.0000 (0.00%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market0.5396+0.0096 (+1.81%)
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close0.5300
Open0.5251
Day range0.48090.5900
52-week range0.28102.0600
Off day high−10.17%
Off 52-week high−74.27%
Volume2.33M
Avg. volume (3M)566.44K
Market cap17.71M
EPS (TTM)-1.59
Forward P/E-1.15
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.44
Shares outstanding33.41M
Short interest0.53% of float
Earnings dateAug 11, 2025 (est.)
Analyst target3.0000
Profit margin0.00%
Against its peers
Compare in full ›| KTTA | PCSA | TPST | NIKI | APRE | SAR.L | |
|---|---|---|---|---|---|---|
| Market cap | 17.71M | 5.41M | 9.26M | 5.27M | 6.36M | 24.00M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -1.2 | -0.5 | -0.4 | — | -1.3 | -0.1 |
| Price/book | 0.4 | -17.0 | -6.8 | 0.1 | 0.3 | 16.3 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −27.79% | −77.18% | −95.29% | −87.43% | −60.75% | +3.33% |
| Today | 0.00% | −0.26% | −1.13% | −3.98% | −1.90% | −2.19% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All KTTA news ›Pasithea Therapeutics Highlights PAS-004’s Potential in NF1 at KOL Event
Posted by Michael Walen on Nov 4th, 2026 Pasithea Therapeutics (NASDAQ:KTTA) outlined the rationale, early clinical profile and market opportunity for its lead MEK inhibitor candidate, PAS-004, during a virtual key opinion leader event…
From the 4Search news index, newest first.